Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT01672736 |
| Title | A Trial of ASP7487 (OSI-906) in Combination With Bortezomib for the Treatment of Relapsed Multiple Myeloma |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | University Health Network, Toronto |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA | CAN |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Emory University Winship Cancer Institute | Atlanta | Georgia | 30322 | United States | Details | |
| University Of Chicago Medical Center | Chicago | Illinois | 60637 | United States | Details | |
| Queen Elizabeth II Health Sciences Center | Halifax | Nova Scotia | B3H2Y9 | Canada | Details | |
| University Health Network-Princess Margaret Hospital | Toronto | Ontario | M5G 2M9 | Canada | Details | |
| Hôpital Maisonneuve-Rosemont | Montreal | Quebec | H1T 2M4 | Canada | Details | |
| Sir Mortimer B. Davis-Jewish General Hospital | Montreal | Quebec | H3T 1E3 | Canada | Details |